JPRN-UMIN000010166已完成2 期
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, and consolidation therapy in elderiy patients with newly diagnosed symptomatic multiple myeloma. - FBMTG-EMM13
Fukuoka Blood and Marrow Transplantation Group0 个研究点目标入组 50 人开始时间: 2013年3月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 66years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Nonsecretory MM and plasma cell leukemia. 2) Known human immunodeficiency virus (HIV) infection or active hepatitis A, B or C. 3) Serious concurrent uncontrolled medical disorder. (hepatic dysfunction, renal failure, cardiac dysfunction, pulmonary dysfunction diabetes, hypertension and infectious diseases) 4) Peripheral neuropathy and neuropathic pain >=Grade 2(CTCAE ver.4.0). 5) History of malignant tumors (except for completely resected in situ carcinoma) during the previous 5 years. 6) Severe uncontrolled psychiatric disorder or illness. 7) Pregnant or lactating female 8) History of hypersensitivity to mannitol or boron. 9) Patients with pneumonia, pulmonary fibrosis or bilateral interstitial abnormalities. 10) Prior steroids treatment (allowed if short term treatment for their general condition or reduction the number of cancer cells) 11) Unwillingness or inability to follow the procedures required in the protocol.
研究者
相似试验
招募中
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed elderly symptomatic multiple myeloma: phase 2 study FBMTG EMM17Multiple myelomaJPRN-UMIN000028421FBMTG49
招募中
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase 2 studyMultiple myelomaJPRN-UMIN000024165JSCT133
已完成
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase2 studyMultiple myelomaJPRN-UMIN000007216Japan Study Group for Cell Therapy and Transplantation56
进行中（未招募）
2 期
ewly diagnosed elderly symptomatic multiple myeloma: phase 2 studyMultiple myelomaJPRN-jRCTs071180031Tanimoto Kazuki49
已完成
2 期
ew drugs for therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase2 study -JSCT MM16Multiple myelomaJPRN-jRCTs071180019Miyamoto Toshihiro141